AstraZeneca shares rally 13%, hit record high as firm gets nod for cancer drug

Astrazeneca Pharma India has received CDSO’s (Central Drugs Standard Control Organisation) nod for the import of Durvalumab for its sale and distribution.

Astrazeneca Pharma India has received CDSO’s (Central Drugs Standard Control Organisation) nod for the import of Durvalumab for its sale and distribution.

Post Content

While SH Kelkar is currently small relative to these global leaders, its technical capabilities are reputable, suggesting potential for substantial market share gains in the long term, according to Kotak.

A government source told CNBC-TV18 that the market coupling of power exchanges is on the cards and will eventually happen.

From August 1, 2024, the Nifty has taken 38 sessions to scale the 26,000 mark.

Year-to-date, foreign investors have poured about $10 billion into the Indian market, but an additional $90 billion is needed to move up to a ‘neutral weight’ position in institutional portfolios. James Sullivan, Head of APAC Research at JPMorgan, explains to…

Dayanand Mittal, JM Financial’s oil and gas analyst also shared his preferred stock picks in the space.

Emkay also mentioned that numerous optionalities have propped up its bull case price target to ₹205 per share.

Given the current climate, many experts suggest that now might be a prudent time to invest in gold.

From Tata Power to Power Grid, Motilal Oswal has initiated coverage on these five power companies with “buy” and “neutral” ratings.